UBS AM’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$65.4K Buy
+2,784
New +$79.6K ﹤0.01% 3341
2021
Q2
– Sell
-5,342
Closed -$295K – 2755
2021
Q1
$295K Buy
5,342
+1,404
+36% +$93.1K ﹤0.01% 2490
2020
Q4
$286K Buy
3,938
+2,865
+267% +$336K ﹤0.01% 2422
2020
Q3
$212K Sell
1,073
-821
-43% -$207K ﹤0.01% 2395
2020
Q2
$530K Buy
1,894
+958
+102% +$224K ﹤0.01% 2103
2020
Q1
$167K Sell
936
-1,062
-53% -$228K ﹤0.01% 2329
2019
Q4
$490K Buy
1,998
+1,062
+113% +$196K ﹤0.01% 2244
2019
Q3
$110K Hold
936
– – ﹤0.01% 2655
2019
Q2
$152K Hold
936
– – ﹤0.01% 2602
2019
Q1
$221K Buy
+936
New +$237K ﹤0.01% 2419

Other funds holding ASMB

UBS AM's ASMB Position: Q3 2026 in Review

UBS AM opened a new position in Assembly Biosciences (ASMB) in Q3 2026: 2,784 shares worth $65.4K. The stake represents ﹤0.01% of the portfolio and ranks #3341 among its holdings. This is a return to the name: UBS AM previously reported a position in ASMB as recently as Q1 2021.

UBS AM first reported a position in ASMB in Q1 2019 and has held it in 10 quarters since. The position peaked at $530K in Q2 2020. 104 funds tracked by Wall St. Rank hold ASMB as of Q3 2026.

  • UBS AM held 2,784 shares of Assembly Biosciences worth $65.4K as of Q3 2026.
  • Assembly Biosciences was a new UBS AM position in Q3 2026.
  • Assembly Biosciences made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3341 holding.
  • UBS AM first reported a position in Assembly Biosciences in Q1 2019 and has held it in 10 quarters since.
  • UBS AM's Assembly Biosciences position peaked at $530K in Q2 2020.
  • 104 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.